Security key
744413105
P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII)
CUSIP: 744413105
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Class A Common Stock, par value $0.0001 per share
- Total 13F shares
- 20,220,830
- Total 13F value
- $4,573,098
- Share change
- -12,236,361
- SEC-reported price per share
- $0.22
- Number of holders
- 39
- Value change
- -$4,169,220
- Number of buys
- 12
- Number of sells
- 28
- Shares outstanding
- 4,740,863
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
39
Top holders
10
PIII full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
P3 Health Partners Inc. SEC filings
P3 Health Partners Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 744413105
Recent filing periods:
Ownership snapshot
Top reported holders of PIII - P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alyeska Investment Group,...
Disclosed value leader
Alyeska Investment Group,...
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 331%
Showing 1-6 of 15 holder rows.
Quick read
Alyeska Investment Group, L.P. leads the comparable SEC ownership view at 331%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alyeska Investment Group, L.P.'s linked filing trail.
Comparable ownership
Top 5
Alyeska Investment Group, L.P.
331%
ARMISTICE CAPITAL, LLC
140%
MORGAN STANLEY
40%
VANGUARD GROUP INC
38%
GEODE CAPITAL MANAGEMENT, LLC
22%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. |
13F
Company
|
331%
|
$6,064,030
15,697,721 shares
|
— | 30 Sep 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
140%
|
$2,568,895
6,650,000 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
40%
|
$735,994
1,905,239 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
38%
|
$702,266
1,819,343 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
22%
|
$397,629
1,029,259 shares
|
— | 30 Sep 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
10%
|
$187,829
486,227 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
20,220,830
Rows available
39
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q4 2024 holders
39
Holder diff
38
| Investor | Q1 2026 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend